drugset
Drugs / sialyl Lewisª-keyhole limpet hemocyanin conjugate vaccine
last change Jan 2020 re-read 9 days ago

sialyl Lewisª-keyhole limpet hemocyanin conjugate vaccine

Vaccine

Developed for
breast cancer
Investigated by
Memorial Sloan Kettering Cancer Center · National Cancer Institute (NCI)

Trials 1

today NCT00470574 · not/applicable
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT00470574 Mar 2007 → Jan 2020 breast cancer Memorial Sloan Kettering Cancer Center Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as sialyl Lewisª-keyhole limpet hemocyanin conjugate vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00470574 ↗
Modality Vaccine “Vaccine Therapy” NCT00470574 ↗
Route Subcutaneous “sialyl Lewisª -keyhole limpet hemocyanin conjugate vaccine subcutaneously (SC)” NCT00470574 ↗